Navigation Links
Last-minute stocking stuffers

Santa arrived a little early this year, and Ive been playing with some new toys that you might find to be perfect last-minute stocking stuffers for the geeks on your list.

You know Kensington as a purveyor of computing accessories, and the good people there were kind enough to send me some of their latest products to try. One of their nicely designed ......

Full article >>>
'"/>

Source:wistechnology.com By Chris Shipley 12/20/04


Page: 1 2 3

Related biology technology :

1. Historic lists - The greatest rock bands, rock guitarists of all time
2. A Midwest life-science odyssey comes full circle
3. A Midwest small-cap, life-science surprise package
4. Madison life-science firms agree to co-develop kidney product
5. Does Milwaukee need a life-science spark?
6. The top 10 misconceptions of life-science patents
7. British, Wisconsin firms explore life-science opportunities together
8. Midwest large-cap life-science sector is solid in first quarter
9. Bio-Logic Systems, another Midwest life-science firm, flies under the radar
10. Midwest life-science company Perrigo globalizes under the radar
11. Recent developments in the protection of trademarks on the Internet
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Last minute stocking stuffers

Breaking Biology Technology:Surety Leads Web Symposium to Address Data Integrity Issues in Bio-Sciences Industry 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 2ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 3ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 4AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 3